Tetraphase On Track For Antibiotic Submission In 2015
This article was originally published in The Pink Sheet Daily
Executive Summary
The biotech reported positive topline data from an interim analysis of its second Phase III trial that puts it on track to release data, submit and potentially see approval next year.